MicroRNAs in cardiac development and remodeling

Pediatric Cardiology

Volumn 31, Issue 3, 2010, Pages 357-362

  Wang, Da Zhi ^a  

^a NONE

Author keywords

Cardiac hypertrophy; Cardiomyopathy; Cardiovascular disease; Heart development; Microrna; Post transcriptional regulation

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 133; MICRORNA 195; MICRORNA 208; MICRORNA 214; UNCLASSIFIED DRUG;

CARDIOMYOPATHY; CELL PROLIFERATION; CONFERENCE PAPER; CONGENITAL HEART DISEASE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HEART DEVELOPMENT; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; NONHUMAN; PROTEIN DEGRADATION; PROTEIN POLYMORPHISM; UPREGULATION;

CARDIOMEGALY; CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; GENE EXPRESSION REGULATION; HEART; HEART FAILURE; HUMANS; MICRORNAS; RISK FACTORS;

EID: 77954758898     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-010-9641-9     Document Type: Conference Paper

References (48)

1. Andl T, Murchison EP, Liu F, Zhang Y, Yunta-Gonzalez M, Tobias JW et al (2006) The miRNA-processing enzyme dicer is essential for the morphogenesis and maintenance of hair follicles. Curr Biol 16:1041-1049.
2. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R et al (2005) Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122:553-563.
3. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ et al (2003) Dicer is essential for mouse development. Nat Genet 35:215-217.
4. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP et al (2009) MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 119:2772-2786.
5. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P et al (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613-638.
6. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029-6033.
7. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM et al (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38:228-233.
8. Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M, Deng Z et al (2008) Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci USA 105:211-216.
9. Cheng AM, Byrom MW, Shelton J, Ford LP (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33:1290-1297.
10. Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H et al (2007) MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play a role in cardiac hypertrophy? Am J Pathol 170:1831-1840.
11. Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibe B et al (2006) A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38:813-818.
12. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M et al (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3:87-98.
13. Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45-79.
14. Giraldez AJ, Cinalli RM, Glasner ME, Enright AJ, Thomson JM, Baskerville S et al (2005) MicroRNAs regulate brain morphogenesis in zebrafish. Science 308:833-838.
15. Griffiths-Jones S, Saini HK, Dongen SV, Enright AJ (2007) miRBase: tools for microRNA genomics. Nucleic Acids Res 36:D154-D158.
16. Harfe BD, McManus MT, Mansfield JH, Hornstein E, Tabin CJ (2005) The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc Natl Acad Sci USA 102:10898-10903.
17. Harris KS, Zhang Z, McManus MT, Harfe BD, Sun X (2006) Dicer function is essential for lung epithelium morphogenesis. Proc Natl Acad Sci USA 103:2208-2213.
18. Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589-600.
19. Humphreys DT, Westman BJ, Martin DI, Preiss T (2005) MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci USA 102:16961-16966.
20. Hunter JJ, Chien KR (1999) Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341:1276-1283.
21. Kiriakidou M, Tan GS, Lamprinaki S, De Planell-Saguer M, Nelson PT, Mourelatos Z (2007) An mRNA m7G cap bindinglike motif within human Ago2 represses translation. Cell 129:1141-1151.
22. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ et al (2005) Combinatorial microRNA target predictions. Nat Genet 37:495-500.
23. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M et al (2005) Silencing of microRNAs in vivo with "antagomirs". Nature 438:685-689.
24. Lee SJ (2004) Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 20:61-86.
25. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
26. Mandel EM, Callis TE, Wang DZ, Conlon FL (2005) Transcriptional mechanisms of congenital heart disease. Drug Discov Today 2:33-38.
27. Mardis ER (2008) The impact of next-generation sequencing technology on genetics. Trends Genet 24:133-141.
28. O'Rourke JR, Georges SA, Seay HR, Tapscott SJ, McManus MT, Goldhamer DJ et al (2007) Essential role for Dicer during skeletal muscle development. Dev Biol 311:359-368.
29. Olson EN (2004) A decade of discoveries in cardiac biology. Nat Med 10:467-474.
30. Olson EN (2006) Gene regulatory networks in the evolution and development of the heart. Science 313:1922-1927.
31. Ransom J, Srivastava D (2007) The genetics of cardiac birth defects. Semin Cell Dev Biol 18:132-139.
32. Rao PK, Kumar RM, Farkhondeh M, Baskerville S, Lodish HF (2006) Myogenic factors that regulate expression of musclespecific microRNAs. Proc Natl Acad Sci USA 103:8721-8726.
33. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N et al (2008) Heart disease and stroke statistics̄2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:e25-e146.
34. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100:416-424.
35. Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W et al (2004) Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350:2682-2688.
36. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY (2006) miR-21- mediated tumor growth. Oncogene 26:2799-2803.
37. Srivastava D, Thomas T, Lin Q, Kirby ML, Brown D, Olson EN (1997) Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat Genet 16:154-160. (Pubitemid 27240613)
38. Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M et al (2007) Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 42:1137-1141.
39. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW et al (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116:258-267.
40. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN (2007) Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316:575-579.
41. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD et al (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103:18255-18260.
42. Wienholds E, Koudijs MJ, van Eeden FJ, Cuppen E, Plasterk RH (2003) The microRNA-producing enzyme Dicer1 is essential for zebrafish development. Nat Genet 35:217-218.
43. Wienholds E, Kloosterman WP, Miska E, Alvarez-Saavedra E, Berezikov E, de Bruijn E et al (2005) MicroRNA expression in zebrafish embryonic development. Science 309:310-311.
44. Xiao J, Luo X, Lin H, Zhang Y, Lu Y, Wang N et al (2007) MicroRNA miR-133 represses HERG K? channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 282:12363-12367.
45. Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H et al (2007) The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 120:3045-3052.
46. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B et al (2007) The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13:486-491.
47. Zhao Y, Samal E, Srivastava D (2005) Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436:214-220.
48. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN et al (2007) Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129:303-317.